Clinical trials have not yet shown that GLP-1RAs can slow the rate of cognitive decline in mild cognitive impairment and mild dementia due to AD
Many GLP-1 promotions target women who are not medically obese or diabetic
Diabetic patients taking Ozempic, metformin, and other diabetes medications are also at risk of hypoglycemia (low blood sugar)
Medications that are most effective may have a higher risk of adverse effects
7.2 Gels, cerium, and selenium nanoparticles In addition to liposomal nanoparticles, functionalized gels, cerium nanoparticles, and selenium nanoparticles can exert anti-tumor effects by affecting T cell subsets or their activity
Genetic Factors That Influence GLP-1 Tolerance The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways